Dai­ichi Sankyo shut­ters an­oth­er R&D cen­ter in an on­go­ing glob­al over­haul

Dai­ichi Phar­ma is clos­ing an­oth­er R&D di­vi­sion. A month af­ter the Japan­ese phar­ma put out the word that it was clos­ing a re­search fa­cil­i­ty in In­dia and ax­ing 170 staffers, Dai­ichi says it will now shut­ter a re­search hub in Japan with 150 in­ves­ti­ga­tors and trans­fer the work to oth­er units.

Asubio Phar­ma has been the dis­cov­ery en­gine at Dai­ichi, based in Kobe and fo­cused on psy­chi­atric and neu­ro­log­i­cal dis­eases, im­mune and in­flam­ma­to­ry dis­eases and re­gen­er­a­tive med­i­cine.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.